Trial intelligence / Profile preview

Injectable antibiotics and fluid support strategies for children with severe pneumonia

PACTR202106720981298Phase 3Recruiting

Sponsor
Research Governance, Ethics & Assurance
Start
Jul 2019
Modality
Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Nanoparticles → Drug Delivery Systems
Countries
1
01

Overview

Phase 3, randomised, open-label trial of benzylpenicillin, ampicillin, gentamicin, ceftriaxone and amoxicillin + clavulanate in pneumonia (6 arms), sponsored by Research Governance, Ethics & Assurance. Started Jul 2019; status: recruiting.

02

Drugs

benzylpenicillinampicillingentamicinceftriaxoneamoxicillin + clavulanate
03

Conditions

pneumonia

Beyond the preview

Go deeper on PACTR202106720981298.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR202106720981298.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call